Avantor® Announces Filing of Registration Statement for Initial Public Offering

Radnor, Pa, February 8, 2019 – Avantor, Inc., a leading global provider of mission critical products and services to customers in the Biopharma, Healthcare, Education & Government, and Advanced Technologies & Applied Materials industries, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating... Read more

Anton Paar Research Award 2018 for Laser Beams and Water Drops

2019-02-08 “At our first Anton Paar Research Award, we were hoping for 25 submissions. In the end, it turned out to be 69,” says Gerhard Murer, chief scientist at Anton Paar. The entries came from 19 countries, most (ten) from Austria, followed by nine each from Brazil, and Germany. The five-member jury – Prof. Ferdinand... Read more

Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research

Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories. Andrew Alliance S.A. and Sartorius today announced the launch of the Andrew Alliance Pipette+ system, which uniquely provides both full traceability and improved repeatability in manual pipetting for life science laboratories. Andrew Alliance, the robotics company... Read more

bioMérieux acquires Invisible Sentinel, a US-based company specialized in food and beverage molecular testing

Marcy l’Étoile, France 07 February, 2019 bioMérieux, a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the acquisition of Invisible Sentinel Inc. This company, based in Philadelphia (PA) develops, manufactures and markets innovative and user-friendly molecular diagnostic tools for the rapid, accurate and reliable detection of pathogens and spoilage organisms in... Read more

IDT backs innovative synthetic biology start-ups with grant awards

CORALVILLE, IA (February 07, 2019) – Demonstrating its commitment to advocating for synthetic biology research, Integrated DNA Technologies’ (IDT) Synthetic Biology Start-up Grant Program has once again benefited innovative start-ups in their missions to impact sustainable manufacturing, human health, and/or humanitarian causes. The program provides much-needed synthetic biology products designed to support the next generation of companies aiming to impact... Read more

Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM) today announced it is one of 11 partners in the TIMID Consortium, a unique effort of six academic institutions and five life science and pharma companies that utilizes both mass cytometry and Imaging Mass Cytometry™ along with other technologies to explore the common cellular basis of... Read more

Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and simple-to-use tissue image analysis for Imaging Mass Cytometry™ (IMC™). Under the terms of the agreement, Fluidigm and Indica Labs will cooperatively promote the next-generation digital pathology image analysis and image management platforms HALO®, HALO AI™and HALO Link™ in conjunction with... Read more

DNAnexus Completes $68 Million Financing

Financing to support expansion in translational informatics and drive adoption of DNAnexus Apollo™, a powerful new platform to advance drug discovery and improve clinical outcomes February 06, 2019 08:00 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., the leader in biomedical informatics and data management, today announced closing a $68 million financing. The funds... Read more

Merck KGaA, Darmstadt, Germany to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline

BILLERICA, Mass., February 6, 2019 — Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, today announced a $70 million investment to expand its state of the art research and development (R&D) facility in Billerica, Massachusetts. The new building will span 145,000 square feet, offering new laboratory... Read more

Dutch Prime Minister Mark Rutte opens Elsevier’s TechHub

Dutch Prime Minister Mark Rutte today opened a new TechHub at the Amsterdam global headquarters of information analytics business Elsevier, a subsidiary of RELX Group. The TechHub will enable world-class talent to combine large data sets with global technology platforms and advanced analytics to create digital tools that help researchers and health workers make better decisions. The... Read more